 Citigroup Inc. increased its position in Cortexyme, Inc. NASDAQ:CRTX by 50.0 in the first quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The firm owned 3,470 shares of the biopharmaceutical companys stock after purchasing an additional 1,157 shares during the quarter. Citigroup Inc.s holdings in ... 